![](https://www.pdfsearch.io/img/ba6b1bf28a642b8b3ab10702e3e17485.jpg) Date: 2016-01-22 10:42:40
| | A Phase 1b Study of the Anti-Cancer Stem Cell Agent Demcizumab (DEM, anti-DLL4) and Gemcitabine (GEM) with or without Nab-Paclitaxel in Patients with Pancreatic Cancer Dose Level – mg/kg Median age (years)Add to Reading ListSource URL: posters.omed.s3.amazonaws.comDownload Document from Source Website File Size: 691,25 KBShare Document on Facebook
|